R-Bendamustine in the treatment of nodular lymphocyte-predominant Hodgkin lymphoma

Show full item record



Permalink

http://hdl.handle.net/10138/305914

Citation

Prusila , R E I , Haapasaari , K-M , Marin , K , Pollari , M , Soini , Y , Vornanen , M , Karjalainen-Lindsberg , M-L , Turpeenniemi-Hujanen , T & Kuittinen , O 2018 , ' R-Bendamustine in the treatment of nodular lymphocyte-predominant Hodgkin lymphoma ' , Acta Oncologica , vol. 57 , no. 9 , pp. 1265-1267 . https://doi.org/10.1080/0284186X.2018.1450522

Title: R-Bendamustine in the treatment of nodular lymphocyte-predominant Hodgkin lymphoma
Author: Prusila, Roosa Enni Inkeri; Haapasaari, Kirsi-Maria; Marin, Katja; Pollari, Marjukka; Soini, Ylermi; Vornanen, Martine; Karjalainen-Lindsberg, Marja-Liisa; Turpeenniemi-Hujanen, Taina; Kuittinen, Outi
Contributor: University of Helsinki, Department of Pathology
Date: 2018
Number of pages: 3
Belongs to series: Acta Oncologica
ISSN: 0284-186X
URI: http://hdl.handle.net/10138/305914
Subject: PHASE-2 TRIAL
RITUXIMAB
DISEASE
MANAGEMENT
THERAPY
3122 Cancers
Rights:
Full text embargoed until: 2019-10-09


Files in this item

Files Size Format View

Embargo on files ends: 2019-10-09

This item appears in the following Collection(s)

Show full item record